Mechanism Identified for Drug Resistance in Glioblastoma Brain Tumors
Duke Health researchers have identified a unique process within the environment of deadly brain tumors that drives resistance to immune-boosting therapies and could be targeted to promote the effects of those drugs.
Duke's Brain Tumor Center Marks 85 Years
The Preston Robert Tisch Brain Tumor Center traces its beginnings to 1937, when Barnes Woodhall, MD, came to Duke as its first chief of neurosurgery (and the only neurosurgeon in North Carolina).
Duke Named Center of Excellence for CCM
Duke University Hospital has been selected as a Center of Excellence for the treatment of brain abnormalities called cerebral cavernous malformations (CCM) in both adults and children.
Women Make Up One-Third of Duke Neurosurgery Residents
In the United States, women make up about 6% of neurosurgeons, and about 16% of neurosurgery residents. Although this number is growing, there is still a sizable gender disparity in residents training to be neurosurgeons.
Emerging Imaging Tools Could Help Predict Brain Aneurysm Rupture Risk
Since his arrival at Duke Neurosurgery in January 2022, David M.
White Glove Service for Brain and Spine Metastasis Patients
The Duke Center for Brain and Spine Metastasis (DCBSM) is one of Duke’s fastest-growing clinical programs.
New Faculty Join the Department of Neurosurgery
Four clinical and research faculty joined Duke Neurosurgery in August 2022.
Duke Neurosurgery Ranks Among Best in Country
Duke Neurosurgery and Duke Neurology have been ranked #23 in the country by U.S.
Duke Neurosurgery Welcomes New Faculty in July
Two faculty members joined the Department of Neurosurgery in July 2022.